Revium Rx (RVRC) Non-Current Assets (2024 - 2025)

Revium Rx recorded quarterly Non-Current Assets of $5.2 million in Q4 2025, down 64.77% quarter-over-quarter from $14.8 million in Q4 2024, and down 64.77% year-over-year from $14.8 million in Q4 2024.

Revium Rx's Non-Current Assets history runs 2 years deep, the most recent figure standing at $5.2 million for Q4 2025.

  • In Q4 2025, Non-Current Assets fell 64.77% year-over-year to $5.2 million; the TTM figure through Dec 2025 stood at $5.2 million (down 64.77% YoY), while the FY2025 annual figure was $5.2 million, down 64.77% from the prior year.
  • Non-Current Assets came in at $5.2 million for Q4 2025 at Revium Rx, down from $14.8 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $14.8 million in Q4 2024 to a low of $5.2 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn 981.71 Mn
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn 3.52 Bn
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn 2.84 Bn
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn 188.72 Mn
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn 179.42 Mn
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn 5.45 Bn
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn 346.03 Mn
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn 451.87 Mn
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn 1.28 Bn
10 Revium Rx - - - 5.20 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 5.20 Mn
Dec 31, 2024 14.77 Mn